These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 26886347)
1. Allometric Scaling of Therapeutic Monoclonal Antibodies Using Antigen Concentration as a Correction Factor: Application to the Human Clearance Prediction. Wang L; Qiang W; Cheng Z J Pharm Sci; 2016 Mar; 105(3):1335-40. PubMed ID: 26886347 [TBL] [Abstract][Full Text] [Related]
2. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach. Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430 [TBL] [Abstract][Full Text] [Related]
3. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? Deng R; Iyer S; Theil FP; Mortensen DL; Fielder PJ; Prabhu S MAbs; 2011; 3(1):61-6. PubMed ID: 20962582 [TBL] [Abstract][Full Text] [Related]
4. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Wang W; Prueksaritanont T Biopharm Drug Dispos; 2010 May; 31(4):253-63. PubMed ID: 20437464 [TBL] [Abstract][Full Text] [Related]
5. Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. Avery LB; Wang M; Kavosi MS; Joyce A; Kurz JC; Fan YY; Dowty ME; Zhang M; Zhang Y; Cheng A; Hua F; Jones HM; Neubert H; Polzer RJ; O'Hara DM MAbs; 2016; 8(6):1064-78. PubMed ID: 27232760 [TBL] [Abstract][Full Text] [Related]
6. Prediction of human pharmacokinetics of therapeutic monoclonal antibodies from simple allometry of monkey data. Oitate M; Masubuchi N; Ito T; Yabe Y; Karibe T; Aoki T; Murayama N; Kurihara A; Okudaira N; Izumi T Drug Metab Pharmacokinet; 2011; 26(4):423-30. PubMed ID: 21606605 [TBL] [Abstract][Full Text] [Related]
7. TNF-α level affects etanercept clearance: TNF-α concentration as a new correction factor of allometric scaling to predict individual etanercept clearances in patients with ankylosing spondylitis. Deng Y; Hu L; Qiang W; Cheng Z; Wang L; Wang X Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):643-651. PubMed ID: 29436715 [TBL] [Abstract][Full Text] [Related]
8. Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data. Li C; Zhang C; Deng R; Leipold D; Li D; Latifi B; Gao Y; Zhang C; Li Z; Miles D; Chen SC; Samineni D; Wang B; Agarwal P; Lu D; Prabhu S; Girish S; Kamath AV Clin Transl Sci; 2019 Sep; 12(5):534-544. PubMed ID: 31115997 [TBL] [Abstract][Full Text] [Related]
9. Interspecies allometric scaling. Part I: prediction of clearance in large animals. Mahmood I; Martinez M; Hunter RP J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787 [TBL] [Abstract][Full Text] [Related]
10. Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction. Dong JQ; Salinger DH; Endres CJ; Gibbs JP; Hsu CP; Stouch BJ; Hurh E; Gibbs MA Clin Pharmacokinet; 2011 Feb; 50(2):131-42. PubMed ID: 21241072 [TBL] [Abstract][Full Text] [Related]
12. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173 [TBL] [Abstract][Full Text] [Related]
13. Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR. Morris ME; Yang X; Gandhi YA; Bhansali SG; Benincosa LJ Biopharm Drug Dispos; 2012 Jan; 33(1):1-14. PubMed ID: 22170504 [TBL] [Abstract][Full Text] [Related]
14. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies. Glassman PM; Balthasar JP J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):427-46. PubMed ID: 27377311 [TBL] [Abstract][Full Text] [Related]
15. Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Caldwell GW; Masucci JA; Yan Z; Hageman W Eur J Drug Metab Pharmacokinet; 2004; 29(2):133-43. PubMed ID: 15230342 [TBL] [Abstract][Full Text] [Related]
16. Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody. Nnane IP; Xu Z; Zhou H; Davis HM Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):219-25. PubMed ID: 25683750 [TBL] [Abstract][Full Text] [Related]
17. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable? Ducongé J; Fernández-Sánchez E; Alvarez D Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220 [TBL] [Abstract][Full Text] [Related]
18. Prediction of human plasma concentration-time profiles of monoclonal antibodies from monkey data by a species-invariant time method. Oitate M; Nakayama S; Ito T; Kurihara A; Okudaira N; Izumi T Drug Metab Pharmacokinet; 2012; 27(3):354-9. PubMed ID: 22146109 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols. Mahmood I; Balian JD Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human. Singh R; Moreno M; Stanimirovic D Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):555-567. PubMed ID: 34120326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]